Evaluation of cytotoxic effects of several novel tetralin derivatives against Hela, MDA-MB-468, and MCF-7 cancer cells

Background: The inhibitors of the enzymes estrone sulfatase and 17-β-hydroxysteroid dehydrogenase (17-β-HSD) could provide a means of blocking estrogen biosynthesis leading to regression of estrogen-dependent tumors. We evaluated the cytotoxicity of several tetralin derivatives, 2-(4-halo-phenylmeth...

Full description

Bibliographic Details
Main Authors: Fateme Shafiee, Hojjat Sadeghi-aliabadi, Farshid Hassanzadeh
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2012-01-01
Series:Advanced Biomedical Research
Subjects:
Online Access:http://www.advbiores.net/article.asp?issn=2277-9175;year=2012;volume=1;issue=1;spage=76;epage=76;aulast=Shafiee
_version_ 1811343377593008128
author Fateme Shafiee
Hojjat Sadeghi-aliabadi
Farshid Hassanzadeh
author_facet Fateme Shafiee
Hojjat Sadeghi-aliabadi
Farshid Hassanzadeh
author_sort Fateme Shafiee
collection DOAJ
description Background: The inhibitors of the enzymes estrone sulfatase and 17-β-hydroxysteroid dehydrogenase (17-β-HSD) could provide a means of blocking estrogen biosynthesis leading to regression of estrogen-dependent tumors. We evaluated the cytotoxicity of several tetralin derivatives, 2-(4-halo-phenylmethylene)-3,4-dihydronaphthalene-1-ones, as potential inhibitors of these two enzymes, on Hela, MDA-MB-468, and MCF-7 cancer cell lines. Materials and Methods: The cell lines were cultured in RPMI medium and the cytotoxic effect of tested compounds (compounds 1 to 5) was screened at the concentrations of 0.1, 1, and 10 μM either alone or in combination with doxorubicin (100 μM), using MTT assay. The mixtures of cell suspension with solvent (1% DMSO in PBS) and doxorubicin (100 μM) were used as negative and positive controls, respectively. Each concentration of compounds was assayed in four wells and repeated in at least three independent experiments for each cell line. The cytotoxic effect of each particular concentration of tested compounds was expressed as the percent of cell survival. Results: None of the compounds exhibited cytotoxic effect (reduction of cell survival to less than 50%) on tested cell lines. However, statistically significant reduction in cell survival was observed for some compounds against particular cell lines. Among all tested combinations of compounds with doxorubicin against cell lines, only compound 4 at 10 μM concentration showed synergistic cytotoxic effect with doxorubicin against Hela cells. Conclusion: With the exception of compound 2, other tested compounds have potential for further cytotoxicity evaluation. Synthesizing other tetralin derivatives similar to compound 4 and studying their structure-activity relationships (SARs) would be encouraged.
first_indexed 2024-04-13T19:28:15Z
format Article
id doaj.art-c15c45ae0ff840e4a4b9643684d46c70
institution Directory Open Access Journal
issn 2277-9175
2277-9175
language English
last_indexed 2024-04-13T19:28:15Z
publishDate 2012-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Advanced Biomedical Research
spelling doaj.art-c15c45ae0ff840e4a4b9643684d46c702022-12-22T02:33:17ZengWolters Kluwer Medknow PublicationsAdvanced Biomedical Research2277-91752277-91752012-01-0111767610.4103/2277-9175.102983Evaluation of cytotoxic effects of several novel tetralin derivatives against Hela, MDA-MB-468, and MCF-7 cancer cellsFateme ShafieeHojjat Sadeghi-aliabadiFarshid HassanzadehBackground: The inhibitors of the enzymes estrone sulfatase and 17-β-hydroxysteroid dehydrogenase (17-β-HSD) could provide a means of blocking estrogen biosynthesis leading to regression of estrogen-dependent tumors. We evaluated the cytotoxicity of several tetralin derivatives, 2-(4-halo-phenylmethylene)-3,4-dihydronaphthalene-1-ones, as potential inhibitors of these two enzymes, on Hela, MDA-MB-468, and MCF-7 cancer cell lines. Materials and Methods: The cell lines were cultured in RPMI medium and the cytotoxic effect of tested compounds (compounds 1 to 5) was screened at the concentrations of 0.1, 1, and 10 μM either alone or in combination with doxorubicin (100 μM), using MTT assay. The mixtures of cell suspension with solvent (1% DMSO in PBS) and doxorubicin (100 μM) were used as negative and positive controls, respectively. Each concentration of compounds was assayed in four wells and repeated in at least three independent experiments for each cell line. The cytotoxic effect of each particular concentration of tested compounds was expressed as the percent of cell survival. Results: None of the compounds exhibited cytotoxic effect (reduction of cell survival to less than 50%) on tested cell lines. However, statistically significant reduction in cell survival was observed for some compounds against particular cell lines. Among all tested combinations of compounds with doxorubicin against cell lines, only compound 4 at 10 μM concentration showed synergistic cytotoxic effect with doxorubicin against Hela cells. Conclusion: With the exception of compound 2, other tested compounds have potential for further cytotoxicity evaluation. Synthesizing other tetralin derivatives similar to compound 4 and studying their structure-activity relationships (SARs) would be encouraged.http://www.advbiores.net/article.asp?issn=2277-9175;year=2012;volume=1;issue=1;spage=76;epage=76;aulast=ShafieeCytotoxicitytetralin derivatives17-β-HSDestrone sulfataseHelaMCF-7MDA-MB-468
spellingShingle Fateme Shafiee
Hojjat Sadeghi-aliabadi
Farshid Hassanzadeh
Evaluation of cytotoxic effects of several novel tetralin derivatives against Hela, MDA-MB-468, and MCF-7 cancer cells
Advanced Biomedical Research
Cytotoxicity
tetralin derivatives
17-β-HSD
estrone sulfatase
Hela
MCF-7
MDA-MB-468
title Evaluation of cytotoxic effects of several novel tetralin derivatives against Hela, MDA-MB-468, and MCF-7 cancer cells
title_full Evaluation of cytotoxic effects of several novel tetralin derivatives against Hela, MDA-MB-468, and MCF-7 cancer cells
title_fullStr Evaluation of cytotoxic effects of several novel tetralin derivatives against Hela, MDA-MB-468, and MCF-7 cancer cells
title_full_unstemmed Evaluation of cytotoxic effects of several novel tetralin derivatives against Hela, MDA-MB-468, and MCF-7 cancer cells
title_short Evaluation of cytotoxic effects of several novel tetralin derivatives against Hela, MDA-MB-468, and MCF-7 cancer cells
title_sort evaluation of cytotoxic effects of several novel tetralin derivatives against hela mda mb 468 and mcf 7 cancer cells
topic Cytotoxicity
tetralin derivatives
17-β-HSD
estrone sulfatase
Hela
MCF-7
MDA-MB-468
url http://www.advbiores.net/article.asp?issn=2277-9175;year=2012;volume=1;issue=1;spage=76;epage=76;aulast=Shafiee
work_keys_str_mv AT fatemeshafiee evaluationofcytotoxiceffectsofseveralnoveltetralinderivativesagainsthelamdamb468andmcf7cancercells
AT hojjatsadeghialiabadi evaluationofcytotoxiceffectsofseveralnoveltetralinderivativesagainsthelamdamb468andmcf7cancercells
AT farshidhassanzadeh evaluationofcytotoxiceffectsofseveralnoveltetralinderivativesagainsthelamdamb468andmcf7cancercells